Editorial: Global excellence in renal pharmacology 2022: Central and South America

Vinicius Andrade-Oliveira; Orestes Foresto-Neto; Niels Olsen Saraiva Câmara

doi:10.3389/fphar.2023.1362010

Editorial: Global excellence in renal pharmacology 2022: Central and South America

Front Pharmacol. 2024 Jan 9:14:1362010. doi: 10.3389/fphar.2023.1362010. eCollection 2023.

Authors

Vinicius Andrade-Oliveira¹, Orestes Foresto-Neto^#^{2

3}, Niels Olsen Saraiva Câmara^#^{2

3}

Affiliations

¹ Bernardo's Lab, Center for Natural and Human Sciences, Federal University of ABC, São Paulo, Brazil.
² Nephrology Division, Universidade Federal de São Paulo, São Paulo, Brazil.
³ Laboratory of Immunobiology of Transplantation, Department of Immunology, Institute of Biomedical Sciences, Universidade de São Paulo, São Paulo, Brazil.

^# Contributed equally.

No abstract available

Keywords: antibiotic; enteroendocine cells; immunossuppression; inflammation; renal pharmacology.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001, CNPq and FAPESP (grant numbers: 2017/05264-7, 2019/02893-9, 2019/14755-0; and 2022/01226-1).